Don’t invest unless you’re prepared to lose all the money you invest. This is a high risk investment and you are unlikely to be protected if something goes wrong.

Novai

Novai
Led by Biotech, Finance, and Pharmaceutical Veterans, Novai has been developing DARC (Detection of Apoptosing Retinal Cells) for over 10 years and has already received over £4m from the Wellcome Trust and UCL to take it to Phase 2 clinical trials (132 Patients to date). DARC combines a patented biomarker and state of the art AI algorithm which allows pharmaceutical companies to reduce the time, cost and risk of developing new drugs. Novai aims to reduce the clinical drug development period from years to months, as well as catch and monitor disease progression in trial patients.
Business Highlights
lock
Video
lock
Investment Deck
lock
Team
lock

03Other opportunities

SFC Angel Fund SEIS cover

SFC Angel Fund XVIII SEIS

The UK's leading SEIS Fund. 24/25 Deployment
Fund Size £3m SEIS
SFC Angel Fund EIS cover

SFC All Star Fund XIV EIS

Invest in SFC’s portfolio stars.
Fund Size £3m EIS